Notice regarding Dividends of Retained Earnings
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO, Gyo Sagara) announced that it resolved to distribute with dividends of retained earnings at the meeting of its Board of Directors held today with the record date of March 31, 2023 as described below.
The matter will be proposed at the 75th Ordinary General Shareholders’ Meeting scheduled for June 22, 2023.
Contents of Dividends
Amount decided Latest forecast for dividends
（Announced on May 11, 2022）
Actual amount in the previous fiscal year
(ended March 2022)
Record date March 31, 2023 March 31, 2023 March 31, 2022 Dividends per share 37.00 yen 33.00 yen 28.00 yen Total dividends 18,071 million yen － 13,673 million yen Effective date June 23, 2023 － June 24,2022 Dividend resource Retained earnings － Retained earnings
Reasons for the Dividends
The Company considers the return of profits to all our shareholders to be one of its most important management policies. We have a basic policy of striving to maintain a stable amount of dividends over the medium to long term and to distribute profits according to business performance.
In the fiscal year ended March 31, 2023, the exchange rate of Japanese yen continued to be weaker against US dollar than expected, and royalty and other income exceeded our initial forecast. We maintained steady performance as we revised our consolidated financial forecast upward on October 31, 2022.
Based on the above policy and taking into comprehensive consideration of the full-year financial results and financial situation, we decided to revise the previously announced year-end dividend forecast to 37.00 yen per share, an increase of 4.00 yen per share. As a result, the annual dividend with the interim dividends is expected to be 70.00 yen per share.
Dividends per share Record date End of second quarter End of fiscal year Total Actual amount
(FY ended March, 2023)
33.00 yen 37.00 yen 70.00 yen Actual amount
(FY ended March, 2022)
28.00 yen 28.00 yen 56.00 yen